Pregabalin Extended Release
- Product NDC
- 50228-464
- 11-digit product format
- 502280464
- Labeler code
- 50228
- Product ID
- 50228-464_e90bfe09-9adb-03c0-e053-2a95a90a061e
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- PREGABALIN
- Dosage form
- TABLET, FILM COATED, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- ScieGen Pharmaceuticals, INC.
- Application
- ANDA215675
- Marketing category
- ANDA
- Marketing start
- 2022-09-14
- Substance
- PREGABALIN
- Active strength
- 330 mg/1
- DEA schedule
- CV
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A215675-001 | PREGABALIN | PREGABALIN | 82.5MG | TABLET, EXTENDED RELEASE / ORAL | 2022-09-14 | ||
| A215675-002 | PREGABALIN | PREGABALIN | 165MG | TABLET, EXTENDED RELEASE / ORAL | 2022-09-14 | ||
| A215675-003 | PREGABALIN | PREGABALIN | 330MG | TABLET, EXTENDED RELEASE / ORAL | 2022-09-14 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | A215675-001 | PREGABALIN | 82.5MG | TABLET, EXTENDED RELEASE / ORAL | 2022-09-14 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A215675-002 | PREGABALIN | 165MG | TABLET, EXTENDED RELEASE / ORAL | 2022-09-14 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A215675-003 | PREGABALIN | 330MG | TABLET, EXTENDED RELEASE / ORAL | 2022-09-14 | 011fe1cb6892… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A215675-001 | PREGABALIN | 82.5MG | TABLET, EXTENDED RELEASE / ORAL | 2022-09-14 | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A215675-002 | PREGABALIN | 165MG | TABLET, EXTENDED RELEASE / ORAL | 2022-09-14 | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A215675-003 | PREGABALIN | 330MG | TABLET, EXTENDED RELEASE / ORAL | 2022-09-14 | 31067a03dcf5… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A215675-001 | PREGABALIN | 82.5MG | TABLET, EXTENDED RELEASE / ORAL | 2022-09-14 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A215675-002 | PREGABALIN | 165MG | TABLET, EXTENDED RELEASE / ORAL | 2022-09-14 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A215675-003 | PREGABALIN | 330MG | TABLET, EXTENDED RELEASE / ORAL | 2022-09-14 | 6a471c1ec25d… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A215675-001 | PREGABALIN | 82.5MG | TABLET, EXTENDED RELEASE / ORAL | 2022-09-14 | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A215675-002 | PREGABALIN | 165MG | TABLET, EXTENDED RELEASE / ORAL | 2022-09-14 | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A215675-003 | PREGABALIN | 330MG | TABLET, EXTENDED RELEASE / ORAL | 2022-09-14 | fd3edfee7708… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A215675-001 | PREGABALIN | 82.5MG | TABLET, EXTENDED RELEASE / ORAL | 2022-09-14 | b8a1b40f171c… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A215675-002 | PREGABALIN | 165MG | TABLET, EXTENDED RELEASE / ORAL | 2022-09-14 | b8a1b40f171c… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A215675-003 | PREGABALIN | 330MG | TABLET, EXTENDED RELEASE / ORAL | 2022-09-14 | b8a1b40f171c… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A215675-001 | PREGABALIN | 82.5MG | TABLET, EXTENDED RELEASE / ORAL | 2022-09-14 | 03ed91905a0d… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A215675-002 | PREGABALIN | 165MG | TABLET, EXTENDED RELEASE / ORAL | 2022-09-14 | 03ed91905a0d… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A215675-003 | PREGABALIN | 330MG | TABLET, EXTENDED RELEASE / ORAL | 2022-09-14 | 03ed91905a0d… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A215675-001 | PREGABALIN | 82.5MG | TABLET, EXTENDED RELEASE / ORAL | 2022-09-14 | 2680178bc6a6… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A215675-002 | PREGABALIN | 165MG | TABLET, EXTENDED RELEASE / ORAL | 2022-09-14 | 2680178bc6a6… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A215675-003 | PREGABALIN | 330MG | TABLET, EXTENDED RELEASE / ORAL | 2022-09-14 | 2680178bc6a6… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A215675-001 | PREGABALIN | 82.5MG | TABLET, EXTENDED RELEASE / ORAL | 2022-09-14 | 5bbf6a4d5a75… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A215675-002 | PREGABALIN | 165MG | TABLET, EXTENDED RELEASE / ORAL | 2022-09-14 | 5bbf6a4d5a75… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A215675-003 | PREGABALIN | 330MG | TABLET, EXTENDED RELEASE / ORAL | 2022-09-14 | 5bbf6a4d5a75… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A215675-001 | PREGABALIN | 82.5MG | TABLET, EXTENDED RELEASE / ORAL | 2022-09-14 | d8e5a09893c0… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A215675-002 | PREGABALIN | 165MG | TABLET, EXTENDED RELEASE / ORAL | 2022-09-14 | d8e5a09893c0… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A215675-003 | PREGABALIN | 330MG | TABLET, EXTENDED RELEASE / ORAL | 2022-09-14 | d8e5a09893c0… | ||
| 2024-10-29 15:01 UTC | 2024-10 | A215675-001 | PREGABALIN | 82.5MG | TABLET, EXTENDED RELEASE / ORAL | 2022-09-14 | d06236e962d9… | ||
| 2024-10-29 15:01 UTC | 2024-10 | A215675-002 | PREGABALIN | 165MG | TABLET, EXTENDED RELEASE / ORAL | 2022-09-14 | d06236e962d9… | ||
| 2024-10-29 15:01 UTC | 2024-10 | A215675-003 | PREGABALIN | 330MG | TABLET, EXTENDED RELEASE / ORAL | 2022-09-14 | d06236e962d9… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A215675-001 | PREGABALIN | 82.5MG | TABLET, EXTENDED RELEASE / ORAL | 2022-09-14 | 79d66fd596c7… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A215675-002 | PREGABALIN | 165MG | TABLET, EXTENDED RELEASE / ORAL | 2022-09-14 | 79d66fd596c7… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A215675-003 | PREGABALIN | 330MG | TABLET, EXTENDED RELEASE / ORAL | 2022-09-14 | 79d66fd596c7… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A215675-001 | PREGABALIN | 82.5MG | TABLET, EXTENDED RELEASE / ORAL | 2022-09-14 | 301d65b070ca… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A215675-002 | PREGABALIN | 165MG | TABLET, EXTENDED RELEASE / ORAL | 2022-09-14 | 301d65b070ca… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A215675-003 | PREGABALIN | 330MG | TABLET, EXTENDED RELEASE / ORAL | 2022-09-14 | 301d65b070ca… | ||
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A215675-001 | PREGABALIN | 82.5MG | TABLET, EXTENDED RELEASE / ORAL | 2022-09-14 | 1e350fbaab3a… | ||
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A215675-002 | PREGABALIN | 165MG | TABLET, EXTENDED RELEASE / ORAL | 2022-09-14 | 1e350fbaab3a… | ||
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A215675-003 | PREGABALIN | 330MG | TABLET, EXTENDED RELEASE / ORAL | 2022-09-14 | 1e350fbaab3a… | ||
| 2024-05-31 18:47 UTC | 2024-05 | A215675-001 | PREGABALIN | 82.5MG | TABLET, EXTENDED RELEASE / ORAL | 2022-09-14 | 8072bd15b7f6… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2023-05-13 08:27 UTC | 2023-05 | A215675-001 | AB | 1 | 053a50430f4f… |
| 2023-05-13 08:27 UTC | 2023-05 | A215675-002 | AB | 1 | 053a50430f4f… |
| 2023-05-13 08:27 UTC | 2023-05 | A215675-003 | AB | 1 | 053a50430f4f… |
| 2023-01-26 05:58 UTC | 2023-01 | A215675-001 | AB | 1 | 3bdfa0b2c4d7… |
| 2023-01-26 05:58 UTC | 2023-01 | A215675-002 | AB | 1 | 3bdfa0b2c4d7… |
| 2023-01-26 05:58 UTC | 2023-01 | A215675-003 | AB | 1 | 3bdfa0b2c4d7… |
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A215675-001 | AB | 1 | 3a93d1ddd44b… |
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A215675-002 | AB | 1 | 3a93d1ddd44b… |
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A215675-003 | AB | 1 | 3a93d1ddd44b… |
| 2022-10-28 04:53 UTC | 2022-10 | A215675-001 | AB | 1 | f41ea6bd6efb… |
| 2022-10-28 04:53 UTC | 2022-10 | A215675-002 | AB | 1 | f41ea6bd6efb… |
| 2022-10-28 04:53 UTC | 2022-10 | A215675-003 | AB | 1 | f41ea6bd6efb… |
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Pregabalin Extended Release
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| PREGABALIN | 330 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 55JG375S6M | Internal UNII lookup |
Harmonized RxCUI identifiers#
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 1544a657-353c-47f8-96ac-a63fa78373f0 | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 441d8579-bd15-4585-93f4-9de3db2d851d | Product name | 4 | 20251114 |
| 594e2c86-3079-4e6e-96c9-48f7a8afc78d | Product name | 1 | 20230718 |
| a62a50ac-1535-4461-9768-8ae703e2e9fb | Product name | 1 | 20210525 |
| 004d1029-ec13-fc89-74f4-3907cf5b6602 | Product name | 2 | 20140523 |
| 9514609b-a2a9-f8ec-6ba6-3f8e5ee89877 | Product name | 1 | 20140508 |
| bc07ef78-e82d-0c19-31f4-31f263780582 | Product name | 1 | 20140508 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 50228-464-05 | Pregabalin Extended Release | 500 in 1 BOTTLE | TABLET, FILM COATED, EXTENDED RE | 500 | 1 | |
| 50228-464-30 | Pregabalin Extended Release | 30 in 1 BOTTLE | TABLET, FILM COATED, EXTENDED RE | 30 | 1 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Pregabalin Extended Release | PREGABALIN | ScieGen Pharmaceuticals, INC. | 1544a657-353c-47f8-96ac-a63fa78373f0 | 2022-09-19 | Warnings, Adverse reactions | 215675 ANDA215675 50228-464 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 1988974 | pregabalin 165 MG 24HR Extended Release Oral Tablet | PSN | 1544a657-353c-47f8-96ac-a63fa78373f0 | 1 |
| 1988977 | pregabalin 330 MG 24HR Extended Release Oral Tablet | PSN | 1544a657-353c-47f8-96ac-a63fa78373f0 | 1 |
| 1988980 | pregabalin 82.5 MG 24HR Extended Release Oral Tablet | PSN | 1544a657-353c-47f8-96ac-a63fa78373f0 | 1 |
| 1988974 | 24 HR pregabalin 165 MG Extended Release Oral Tablet | SCD | 1544a657-353c-47f8-96ac-a63fa78373f0 | 1 |
| 1988977 | 24 HR pregabalin 330 MG Extended Release Oral Tablet | SCD | 1544a657-353c-47f8-96ac-a63fa78373f0 | 1 |
| 1988980 | 24 HR pregabalin 82.5 MG Extended Release Oral Tablet | SCD | 1544a657-353c-47f8-96ac-a63fa78373f0 | 1 |
Packages#
| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 50228-464-05 | 50228046405 | 500 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (50228-464-05) | 2022-09-14 | 0000-00-00 | No | No | Current |
| 50228-464-30 | 50228046430 | 30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (50228-464-30) | 2022-09-14 | 0000-00-00 | No | No | Current |